Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Immunotherapy with peptides.

Moldaver D, Larché M.

Allergy. 2011 Jun;66(6):784-91. doi: 10.1111/j.1398-9995.2011.02610.x. Epub 2011 Apr 20. Review.

2.

Epitope peptides and immunotherapy.

Tanabe S.

Curr Protein Pept Sci. 2007 Feb;8(1):109-18. Review.

PMID:
17305564
3.

Recent progress in allergen immunotherapy.

Nouri-Aria KT.

Iran J Immunol. 2008 Mar;5(1):1-24. doi: IJIv5i1A1. Review.

PMID:
18319521
4.

Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.

O'Hehir RE, Sandrini A, Anderson GP, Rolland JM.

Curr Med Chem. 2007;14(21):2235-44. Review.

PMID:
17896972
5.

Allergen-related approaches to immunotherapy.

Rolland JM, Gardner LM, O'Hehir RE.

Pharmacol Ther. 2009 Mar;121(3):273-84. doi: 10.1016/j.pharmthera.2008.11.007. Epub 2008 Dec 7. Review.

PMID:
19111571
6.

Allergen immunotherapy with cat allergen peptides.

Kay AB, Larché M.

Springer Semin Immunopathol. 2004 Feb;25(3-4):391-9. Epub 2003 Sep 30. Review.

PMID:
15007637
7.

Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.

Focke M, Swoboda I, Marth K, Valenta R.

Clin Exp Allergy. 2010 Mar;40(3):385-97. doi: 10.1111/j.1365-2222.2009.03443.x.

PMID:
20210812
8.

Peptide immunotherapy for allergic diseases.

Larché M.

Allergy. 2007 Mar;62(3):325-31. Review.

9.

Peptide therapy for allergic diseases: basic mechanisms and new clinical approaches.

Larché M.

Pharmacol Ther. 2005 Dec;108(3):353-61. Epub 2005 Jul 12. Review.

PMID:
16014312
10.

Immunological mechanisms of allergen-specific immunotherapy.

Jutel M, Akdis CA.

Allergy. 2011 Jun;66(6):725-32. doi: 10.1111/j.1398-9995.2011.02589.x. Epub 2011 Apr 6. Review.

11.

Non-anaphylactic combination of partially deleted fragments of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.

Takai T, Mori A, Yuuki T, Okudaira H, Okumura Y.

Mol Immunol. 1999 Oct-Nov;36(15-16):1055-65.

PMID:
10698308
12.

New insight into immunological mechanisms of venom immunotherapy.

Ewan PW.

Curr Opin Allergy Clin Immunol. 2001 Aug;1(4):367-74. Review.

PMID:
11964715
13.

Peptide-mediated immune responses in specific immunotherapy.

Haselden BM, Kay AB, Larché M.

Int Arch Allergy Immunol. 2000 Aug;122(4):229-37. Review.

PMID:
10971112
14.

Recombinant allergens for immunotherapy. Where do we stand?

Niederberger V, Valenta R.

Curr Opin Allergy Clin Immunol. 2004 Dec;4(6):549-54. Review.

PMID:
15640698
15.

Update on the current status of peptide immunotherapy.

Larché M.

J Allergy Clin Immunol. 2007 Apr;119(4):906-9. Review.

PMID:
17418662
16.

Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.

Möbs C, Slotosch C, Löffler H, Jakob T, Hertl M, Pfützner W.

J Immunol. 2010 Feb 15;184(4):2194-203. doi: 10.4049/jimmunol.0901379. Epub 2010 Jan 4.

17.

Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.

Jutel M, Akdis M, Blaser K, Akdis CA.

Allergy. 2006 Jul;61(7):796-807. Review.

18.

Immune mechanisms of allergen-specific sublingual immunotherapy.

Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L.

Allergy. 2006 Feb;61(2):151-65. Review.

19.

New strategies for allergen immunotherapy.

Carnés J, Robinson DS.

Recent Pat Inflamm Allergy Drug Discov. 2008 Jun;2(2):92-101. Review.

PMID:
19075996
20.

Engineered allergens for immunotherapy.

Bhalla PL, Singh MB.

Curr Opin Allergy Clin Immunol. 2004 Dec;4(6):569-73. Review.

PMID:
15640701

Supplemental Content

Support Center